Anyuan’s API manufacturing facility in Northern part of Jiangsu province can support production from kg to ton scale of APIs or pharmaceutical intermediates. Anyuan’s new cGMP facility is under construction and is expected to be in full operation in 2011. Anyuan also manufactures final drug products through a strategic partner.